Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response. - Wikidata - awgldk - TriplyDB

Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response.

Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response.

http://www.wikidata.org/entity/Q34200863

about

Management of atopic dermatitis: safety and efficacy of phototherapy Immune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted Therapeutics Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches New era of biologic therapeutics in atopic dermatitis The ABC's of managing patients with severe atopic dermatitis Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology.Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis.Comparing performance of Chromameter®, Mexameter® and full-field laser perfusion imaging for measurement of ultraviolet B light-induced erythema.Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part II): Systemic Treatment.Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis T Helper 1 and T Helper 2 Cytokines Differentially Modulate Expression of Filaggrin and its Processing Proteases in Human Keratinocytes Heat-Killed Enterococcus faecalis EF-2001 Ameliorates Atopic Dermatitis in a Murine Model.Inhibition of inflammatory reactions in 2,4-Dinitrochlorobenzene induced Nc/Nga atopic dermatitis mice by non-thermal plasma Pathways to managing atopic dermatitis: consensus from the experts Atopic dermatitis and vitamin D: facts and controversies.Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.Immunology of atopic eczema: overcoming the Th1/Th2 paradigm.Role of vitamin D in the pathogenesis and treatment of atopic dermatitis.Apremilast for the treatment of psoriatic arthritis.Treatment of Eczema: Corticosteroids and Beyond.Drug evaluation review: dupilumab in atopic dermatitis.The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.Atopic dermatitis in older adults: A viewpoint from geriatric dermatology.Circulating CLA+ T cells in atopic dermatitis and their possible role as peripheral biomarkers.Baicalein increases keratin 1 and 10 expression in HaCaT keratinocytes via TRPV4 receptor activation.Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis.Prostaglandin E2 stimulates adaptive IL-22 production and promotes allergic contact dermatitis.Expression of IL-22 in the Skin Causes Th2-Biased Immunity, Epidermal Barrier Dysfunction, and Pruritus via Stimulating Epithelial Th2 Cytokines and the GRP Pathway.Nonlesional atopic dermatitis skin shares similar T-cell clones with lesional tissues.AhR mediates an anti-inflammatory feedback mechanism in human Langerhans cells involving FcεRI and IDO.Phototherapy in Atopic Dermatitis.A Mouse Model for Atopic Dermatitis Using Topical Application of Vitamin D3 or of Its Analog MC903.

P2860

Q26778443-718560DB-B5D0-4512-B709-CBFDC5D7F1EA Q26799532-421E21B3-3BFB-4935-8F31-D7EE07CA94A5 Q26852335-A270D828-7E90-4AE3-8F08-96A34B38E957 Q27001941-99FD589F-F6EA-4C7B-943D-4FD6C500BF5F Q27022610-FC931615-F0F7-4886-A36C-ABD353D2A64D Q34006054-C10E19E6-8ABC-456A-A808-05C94A4AE7F3 Q34797596-66CC5441-9DFA-49A0-998C-99CD0A4460E8 Q35561678-11B7E03D-F9D3-4E2E-AA29-91B5B4911039 Q35803992-B714DBA8-C037-4092-AAF8-1203D94F1077 Q36214254-E85034B6-E691-4D36-B60B-6A98FC03E24B Q36580238-6EE9009B-050D-4A78-86CA-82952750BC83 Q36705578-04FE3DDC-8508-4B3B-975B-860E040A3EBC Q36732085-628FAE80-E9AE-4D54-93C2-602E01D85502 Q36980186-7EF6ECE8-3520-4C4F-A2E0-743C7CC250CA Q37258723-67595C18-4004-4443-AED8-30DB16CB06C5 Q37509446-5958AD3A-DC44-44F3-9D8A-5CE280AE4722 Q37709674-831B7D18-54AC-4886-866F-CFA1B410739D Q38124385-617B26E6-2294-4EA4-A04E-CD664C2353CB Q38131033-BAFE79F7-5C71-4643-94C8-0236FA646FD4 Q38202205-E7CE8CD7-7F55-403C-91EF-C71775EEEDAB Q38419338-9694D9AE-7A8E-4B62-8F34-24391215B173 Q38645192-5A1EBD63-2B3C-4A6E-A686-A22055174471 Q38733182-C52FA3B7-3881-425B-8A00-D66361021786 Q38790589-52343D9C-7A82-498F-9A54-5AAA5A4413F9 Q38793743-1D4D6CF1-B92A-4E37-B55A-B66C66F9D1F2 Q46566713-028C08BC-7BE8-41E8-90B0-C462BAFD5A36 Q47171494-F6C51775-6BE9-4878-8841-091A21090AAC Q47865957-A7B776C5-37B6-43C6-8025-68390C15135E Q48205671-AFFA6CE6-DFA1-4950-A272-93EADFB2DA32 Q48298664-900C44A9-BECD-4A63-87EA-44D8599C880E Q48321721-79A418A3-08A3-4E14-8E18-D41CC4F39767 Q50074897-0850DA97-D09D-4944-8754-84BF33B7EBE4 Q52930714-91CC3A7F-5B17-4832-85B9-18934921EDAD

P2860

Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response.

http://www.wikidata.org/entity/Q34200863

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Reversal of atopic dermatitis ...... kers for therapeutic response.

@ast

Reversal of atopic dermatitis ...... kers for therapeutic response.

@en

Reversal of atopic dermatitis ...... kers for therapeutic response.

@nl

type

label

Reversal of atopic dermatitis ...... kers for therapeutic response.

@ast

Reversal of atopic dermatitis ...... kers for therapeutic response.

@en

Reversal of atopic dermatitis ...... kers for therapeutic response.

@nl

prefLabel

Reversal of atopic dermatitis ...... kers for therapeutic response.

@ast

Reversal of atopic dermatitis ...... kers for therapeutic response.

@en

Reversal of atopic dermatitis ...... kers for therapeutic response.

@nl

P1433

Q34200863-ECF44A11-B3D9-405C-91A0-F0D471D09E08

P1476

Q34200863-8E974629-BB84-4403-84EE-B78995DF422A

P2093

Q34200863-378C5E28-4AF7-46AF-BDF4-4E6DE8E47AA0

Q34200863-3CF3E7FC-71F1-4DF2-9098-F66A9B3CEB36

Q34200863-4B7B1E21-A102-42AD-B9CC-1C03D7A6B8BB

Q34200863-51AE2C62-5C82-4DB7-B789-2B5C8E65C73A

Q34200863-73DC761D-5283-43BA-90F5-221017DC2318

Q34200863-ADCDC613-CE99-436B-B48F-CE85BB4EEED9

Q34200863-B93177B8-F5F3-4E6B-87DB-FA22D5059903

Q34200863-C16A93BA-550A-4E32-B678-D544BC69D474

Q34200863-C8AFA443-DBD5-4CA7-9DC3-AAB491DB72C8

Q34200863-DA816D04-9D38-4782-ADE1-A27E2ED0F2CB

P2860

Q34200863-0348764F-DFF6-410F-B6BB-B48747F76E5E

Q34200863-08E9C7FE-7248-42F7-98C0-38A9D46BBEBA

Q34200863-24EDE16E-B04B-4323-9752-4456ADD8C71A

Q34200863-260B3176-231F-466E-831B-D83CA0C74442

Q34200863-2B550518-9A56-44D3-9530-0D50C179FDFA

Q34200863-2D59BFBE-2374-456F-ABE7-2A64C0EB8261

Q34200863-30661FE2-EDBB-4B5C-95FB-E33DD90DB8B2

Q34200863-30B95AC0-E235-4202-B17E-606DCBB8008B

Q34200863-3ACC3A08-12C1-49A5-92F6-4E0C6086A59B

Q34200863-3E3CCD9E-8C19-48DA-9538-EB16999545E6

P304

Q34200863-8E2375BA-037E-42D4-8983-EB76994E02C3

P31

Q34200863-32E82196-4124-4897-B5D0-3EF2BB6E5E9E

P356

Q34200863-49D55FE0-2A4E-489A-9E51-EAC699D380AF

P407

Q34200863-20720CC3-8628-4089-A4DF-4256BD3CB4B5

P433

Q34200863-A08C3B27-F49D-47B2-9BB3-27048D925A1D

P478

Q34200863-15DDF288-8F4C-49C3-902F-11A9F35344DA

P50

Q34200863-04049D43-50A6-408C-9768-C1DF1C75C000

P577

Q34200863-D2233176-B79D-487F-891E-85777F52807F

P5875

Q34200863-48896D67-7AA4-451A-A011-69C0B93D9ED1

P698

Q34200863-200F3F77-48EB-42E2-A0CF-58FDE8E379B8

P921

Q34200863-13F18E4A-E913-44B5-8017-51D2BDB7A7CF

P932

Q34200863-3A2A9225-F62A-46AF-BB19-4A73F278B2C1

P356

J.JACI.2011.05.042

P1433

The Journal of Allergy and Clinical Immunology

P1476

Reversal of atopic dermatitis ...... kers for therapeutic response.

@en

P2093

Andrea Chiricozzi

http://www.w3.org/2001/XMLSchema#string

Avner Shemer

http://www.w3.org/2001/XMLSchema#string

Emma Guttman-Yassky

http://www.w3.org/2001/XMLSchema#string

Hideki Fujita

http://www.w3.org/2001/XMLSchema#string

Irma Cardinale

http://www.w3.org/2001/XMLSchema#string

James G Krueger

http://www.w3.org/2001/XMLSchema#string

Leanne Johnson-Huang

http://www.w3.org/2001/XMLSchema#string

Mary Sullivan-Whalen

http://www.w3.org/2001/XMLSchema#string

Mayte Suárez-Fariñas

http://www.w3.org/2001/XMLSchema#string

Patricia Gilleaudeau

http://www.w3.org/2001/XMLSchema#string

P2860

Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis

Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis

Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis.

A rapid flow cytometric assay to detect CD4+ and CD8+ T-helper (Th) 0, Th1 and Th2 cells in whole blood and its application to study cytokine levels in atopic dermatitis before and after cyclosporin therapy.

Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production.

Recent insights into atopic dermatitis and implications for management of infectious complications.

Mechanisms of ultraviolet (UV) B and UVA phototherapy.

IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells.

P304

583-93.e1-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACI.2011.05.042

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P50

Anne M. Bowcock

P577

2011-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51496268

http://www.w3.org/2001/XMLSchema#string

P698

21762976

http://www.w3.org/2001/XMLSchema#string

P921

P932

3448950

http://www.w3.org/2001/XMLSchema#string